Skip to main content
. 2013 Jul-Sep;34(3):213–220. doi: 10.4103/0971-5851.123748

Table 4.

Selection of second generation tyrosine kinase inhibitor based on the mutation identified

graphic file with name IJMPO-34-213-g005.jpg